{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:33:45Z","timestamp":1788845625541,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 2026 Id. 21440"],"award-info":[{"award-number":["IG 2026 Id. 21440"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondazione Buzzi Unicem"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"DOI":"10.1038\/s41419-021-04178-6","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T04:28:59Z","timestamp":1632457739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunogenic cell death and immunogenic surrender: related but distinct mechanisms of immune surveillance"],"prefix":"10.1038","volume":"12","author":[{"given":"Rosanna","family":"Mezzapelle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5329-6445","authenticated-orcid":false,"given":"Marco E.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-9670","authenticated-orcid":false,"given":"Massimo P.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"4178_CR1","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science. 2018;359:1350\u20135.","journal-title":"Science"},{"key":"4178_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2020-SITC2020.0001","volume":"8","author":"L Galluzzi","year":"2020","unstructured":"Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Buqu\u00e9 Martinez A, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. J Immunother Cancer. 2020;8:1\u201321.","journal-title":"J Immunother Cancer"},{"key":"4178_CR3","doi-asserted-by":"publisher","first-page":"e12344","DOI":"10.15252\/emmm.202012344","volume":"13","author":"R Mezzapelle","year":"2021","unstructured":"Mezzapelle R, De Marchis F, Passera C, Leo M, Brambilla F, Colombo F, et al. CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma. EMBO Mol Med. 2021;13:e12344.","journal-title":"EMBO Mol Med"},{"key":"4178_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.tcb.2020.09.002","volume":"30","author":"M Gonz\u00e1lez-Quiroz","year":"2020","unstructured":"Gonz\u00e1lez-Quiroz M, Blondel A, Sagredo A, Hetz C, Chevet E, Pedeux R. When endoplasmic reticulum proteostasis meets the DNA damage response. Trends Cell Biol. 2020;30:881\u201391.","journal-title":"Trends Cell Biol"},{"key":"4178_CR5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41418-017-0044-9","volume":"25","author":"L Bezu","year":"2018","unstructured":"Bezu L, Sauvat A, Humeau J, Gomes-da-Silva LC, Iribarren K, Forveille S, et al. eIF2\u03b1 phosphorylation is pathognomonic for immunogenic cell death. Cell Death Differ. 2018;25:1375\u201393.","journal-title":"Cell Death Differ"},{"key":"4178_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imr.12601","volume":"280","author":"ME Bianchi","year":"2017","unstructured":"Bianchi ME, Crippa MP, Manfredi AA, Mezzapelle R, Rovere Querini P, Venereau E. High-mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair. Immunol Rev. 2017;280:74\u201382.","journal-title":"Immunol Rev"},{"key":"4178_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1071059","volume":"296","author":"P Matzinger","year":"2002","unstructured":"Matzinger P. The danger model: a renewed sense of self. Science. 2002;296:301\u20135.","journal-title":"Science"},{"key":"4178_CR8","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.phrs.2016.06.031","volume":"111","author":"E Venereau","year":"2016","unstructured":"Venereau E, De Leo F, Mezzapelle R, Careccia G, Musco G, Bianchi ME. HMGB1 as biomarker and drug target. Pharmacol Res. 2016;111:534\u201344.","journal-title":"Pharmacol Res"},{"key":"4178_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.153","volume":"6","author":"H Yang","year":"2015","unstructured":"Yang H, Pellegrini L, Napolitano A, Giorgi C, Jube S, Preti A, et al. Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression. Cell Death Dis. 2015;6:e1786.","journal-title":"Cell Death Dis"},{"key":"4178_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep22850","volume":"6","author":"R Mezzapelle","year":"2016","unstructured":"Mezzapelle R, Rrapaj E, Gatti E, Ceriotti C, De Marchis F, Preti A, et al. Human malignant mesothelioma is recapitulated in immunocompetent BALB\/c mice injected with murine AB cells. Sci Rep. 2016;6:22850.","journal-title":"Sci Rep"},{"key":"4178_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","volume":"32","author":"AN Barclay","year":"2014","unstructured":"Barclay AN, Van Den Berg TK. The interaction between signal regulatory protein alpha (SIRP\u03b1) and CD47: structure, function, and therapeutic target. Annu Rev Immunol. 2014;32:25\u201350.","journal-title":"Annu Rev Immunol"},{"key":"4178_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1084\/jem.194.4.541","volume":"194","author":"BR Blazar","year":"2001","unstructured":"Blazar BR, Lindsberg FP, Ingulli E, Panoskaltsis-Mortari PA, Oldenborg PA, Iizuka K, et al. CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells. J Exp Med. 2001;194:541\u201350.","journal-title":"J Exp Med"},{"key":"4178_CR13","doi-asserted-by":"publisher","first-page":"6662","DOI":"10.1073\/pnas.1121623109","volume":"109","author":"SB Willingham","year":"2012","unstructured":"Willingham SB, Volkmer JP, Gentles AJ, Sahoo D, Dalerba P, Mitra SS, et al. The CD47-signal regulatory protein alpha (SIRP\u03b1) interaction is a therapeutic target for human solid tumors. Proc Natl Acad Sci USA. 2012;109:6662\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4178_CR14","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm.3931","volume":"21","author":"X Liu","year":"2015","unstructured":"Liu X, Pu Y, Cron K, Deng L, Kline J, Frazier WA, et al. CD47 blockade triggers T cell-mediated destruction of immunogenic tumors. Nat Med. 2015;21:1209\u201315.","journal-title":"Nat Med"},{"key":"4178_CR15","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3389\/fimmu.2020.02109","volume":"11","author":"ME Bianchi","year":"2020","unstructured":"Bianchi ME, Mezzapelle R. The chemokine receptor CXCR4 in cell proliferation and tissue regeneration. Front Immunol. 2020;11:2109.","journal-title":"Front Immunol"},{"key":"4178_CR16","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 2007;13:1050\u20139.","journal-title":"Nat Med"},{"key":"4178_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/cdd.2013.72","volume":"21","author":"T Yamazaki","year":"2014","unstructured":"Yamazaki T, Hannani D, Poirier-Colame V, Ladoire S, Locher C, Sistigu A, et al. Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists. Cell Death Differ. 2014;21:69\u201378.","journal-title":"Cell Death Differ"},{"key":"4178_CR18","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.chom.2010.11.006","volume":"8","author":"KYC Chow","year":"2010","unstructured":"Chow KYC, Brotin E, Khalifa YB, Carthagena L, Teissier S, Danckaert A, et al. A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome. Cell Host Microbe. 2010;8:523\u201333.","journal-title":"Cell Host Microbe"},{"key":"4178_CR19","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1038\/sj.onc.1202608","volume":"18","author":"N Nakamura","year":"1999","unstructured":"Nakamura N, Fujii M, Tsukahara T, Arai M, Ohashi T, Wakao H, et al. Human T-cell leukemia virus type 1 Tax protein induces the expression of STAT1 and STAT5 genes in T-cells. Oncogene. 1999;18:2667\u201375.","journal-title":"Oncogene"}],"container-title":["Cell Death & Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04178-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04178-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:06:49Z","timestamp":1669972009000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-04178-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":19,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["4178"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-04178-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"assertion":[{"value":"23 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were approved by the Animal Care and Use Committee (IACUC #839) of Ospedale San Raffaele in accordance with the Italian law.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"M.E.B. is founder and part owner of HMGBiotech. The other authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"869"}}